Projections of Drug-Drug Interactions Caused by Time-Dependent Inhibitors of Cytochrome P450 1A2, 2B6, 2C8, 2C9, 2C19, and 2D6 Using In Vitro Data in Static and Dynamic Models
Drug Metabolism and Disposition · 2024
DOI: 10.1124/dmd.124.001660 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2024. Verfasst von Elaine Tseng und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pfizer Global Research and Development, Pfizer Inc, United States elaine.tseng@pfizer.com. Hauptthemen laut MEDLINE: Microsomes, Liver, Models, Biological, Cytochrome P-450 Enzyme Inhibitors, Cytochrome P-450 Enzyme System. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Abstract (Originalsprache)
In vitro time-dependent inhibition (TDI) kinetic parameters for cytochrome P450 (CYP) 1A2, 2B6, 2C8, 2C9, 2C19, and 2D6, were determined in pooled human liver microsomes for 19 drugs (and 2 metabolites) for which clinical drug-drug interactions (DDI) are known. In vitro TDI data were incorporated into the projection of the magnitude of DDIs using mechanistic static models and Simcyp®. Results suggest that for the mechanistic static model, use of estimated average unbound exit concentration of the inhibitor from the liver resulted in a successful prediction of observed magnitude of clinical DDIs and was similar to Simcyp®. Overall, predictions of DDI magnitude (i.e., fold increase in AUC of a CYP-specific marker substrate) were within 2-fold of actual values. Geometric mean-fold errors were 1.7 and 1.6 for static and dynamic models, respectively. Projections of DDI from both models were also highly correlated to each other (r2 = 0.92). This investigation demonstrates that DDI can be reliably predicted from in vitro TDI data generated in HLM for several CYP enzymes. Simple mechanistic static model equations as well as more complex dynamic PBPK models can be employed in this process. Significance Statement Cytochrome P450 time-dependent inhibitors (TDI) can cause drug-drug interactions (DDI). An ability to reliably assess the potential for a new drug candidate to cause DDI is essential during drug development. In this report, TDI data for 19 drugs (and 2 metabolites) were measured and used in static and dynamic models to reliably project the magnitude of DDI resulting from inhibition of CYP1A2, 2B6, 2C8, 2C9, 2C19, and 2D6.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pfizer Global Research and Development, Pfizer Inc, United States elaine.tseng@pfizer.com.
- PDM, Pfizer Inc, United States.
- Pfizer Inc, retiree, United States.
- Pfizer Inc, United States.
- Pharmacokinetics, Dynamics & Metabolism, Pfizer, Inc, United States.
- Groton Laboratories, Pfizer Inc., United States.
ORCID-Profile: Elaine Tseng
Zitieren
APA
Tseng, E., Lin, J., Strelevitz, T. J., DaSilva, E., Goosen, T. C., & Obach, R. S. (2024). Projections of Drug-Drug Interactions Caused by Time-Dependent Inhibitors of Cytochrome P450 1A2, 2B6, 2C8, 2C9, 2C19, and 2D6 Using In Vitro Data in Static and Dynamic Models. Drug Metabolism and Disposition. https://doi.org/10.1124/dmd.124.001660
Vancouver
Tseng E, Lin J, Strelevitz TJ, DaSilva E, Goosen TC, Obach RS. Projections of Drug-Drug Interactions Caused by Time-Dependent Inhibitors of Cytochrome P450 1A2, 2B6, 2C8, 2C9, 2C19, and 2D6 Using In Vitro Data in Static and Dynamic Models. Drug Metabolism and Disposition. 2024. doi:10.1124/dmd.124.001660
BibTeX
@article{Tseng2024,
author = {Tseng, Elaine and Lin, Jian and Strelevitz, Timothy J and DaSilva, Ethan and Goosen, Theunis C and Obach, R Scott},
title = {Projections of Drug-Drug Interactions Caused by Time-Dependent Inhibitors of Cytochrome P450 1A2, 2B6, 2C8, 2C9, 2C19, and 2D6 Using In Vitro Data in Static and Dynamic Models},
journal = {Drug Metabolism and Disposition},
year = {2024},
doi = {10.1124/dmd.124.001660}
}
EUVIMED